Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Key considerations include: Disease activity status : Active inflammation may increase susceptibility to adverse effects Nutritional state : Patients already experiencing malabsorption or weight loss may not be appropriate candidates for medications that further reduce appetite Stricture presence : Delayed gastric emptying could theoretically worsen symptoms in patients with bowel narrowing Medication interactions : While subcutaneous semaglutide has minimal effects on most oral drug absorption, specific medications (such as levothyroxine with oral semaglutide/Rybelsus) may require monitoring Hypoglycemia risk : For patients with diabetes using insulin or sulfonylureas, dose reductions of these medications may be needed when starting semaglutide Diabetic retinopathy : Patients with pre-existing diabetic retinopathy should be monitored for worsening eye disease There is currently insufficient evidence to provide definitive guidance, making shared decision-making between patient and healthcare team essential
At WellSpot IV, were here to help you take that first step toward feeling strong and mobile again
Yes, and it's often beneficial
Psychother Psychosomatics
Whilst Ozempic does not directly treat arthritis, understanding the relationship between weight management and joint health is important for patients exploring treatment options
